🔴 Eli Lilly and Company is trading 2.8% down today as profit-taking extends multi-day slide

Eli Lilly and Company is trading 2.8% down at $28,780.00, extending a multi-day slide from $30,340.00 on June 15 as investors lock in recent gains.

• No fresh company-specific news, earnings, regulatory decisions, or major analyst calls dated June 18–19 have been identified to explain the move.
• The decline follows a period of significant strength tied to optimism over obesity drugs and the expansion of CVS Caremark coverage earlier in June.
• The current pullback appears to be a normal bout of profit-taking and market positioning rather than a reaction to a new fundamental headline.